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In the present study, the effects of nanocrystalline hydroxyapatite (nano-HA) and 
nanocrystalline Si-substituted hydroxyapatite (nano-SiHA) on osteoclast differentiation and 
resorptive activity have been evaluated in vitro using osteoclast-like cells. The action of these 
materials on proinflammatory and reparative macrophage populations was also studied. Nano-
SiHA disks delayed the osteoclast differentiation and decreased the resorptive activity of these 
cells on their surface, as compared to nano-HA samples, without affecting cell viability. 
Powdered nano-SiHA also induced an increase of the reparative macrophage population. These 
results along with the beneficial effects on osteoblasts previously observed with powdered 
nano-SiHA suggest the potential of this biomaterial for modulating the fundamental processes 
of bone formation and turnover, preventing bone resorption and enhancing bone formation at 
implantation sites in treatment of osteoporotic bone and in bone repair and regeneration. 
1. Introduction 
 Bone is a dynamic tissue in continuous remodelling which 
depends on resorption and new bone formation processes 
carried out by osteoclasts and osteoblasts respectively, working 
together in basic multicellular units. The main purpose of bone 
remodelling is to repair micro-fractures and maintain mineral 
homeostasis by providing access to stores of calcium and 
phosphate.1 Imbalances in bone turnover lead to bone loss and 
development of osteoporosis and ultimately fracture. Thus, 
osteoclasts, as principal bone-resorbing cells, are involved in 
the pathogenesis of various bone diseases, including 
osteoporosis.2,3 Severe bone loss due to excessive bone 
resorption is also observed in bacterial infection-related 
inflammatory diseases, such as periodontitis, osteomyelitis, and 
some types of arthritis.4 Osteoclasts are multinucleated giant 
cells which differentiate from hematopoietic stem cells (HSC) 
through different consecutive steps regulated by several growth 
factors and cytokines expressed by different cell types present 
at bone.5-7 HSC give rise to circulating mononuclear cells 
termed colony forming unit-granulocyte/macrophage (CFU-
GM) whose proliferation is stimulated by macrophage/ 
monocyte-colony forming factor (M-CSF), maintaining a pool 
of mononuclear cells in monocyte/macrophage lineage which 
are osteoclast precursors.8,9 These mononuclear precursors are 
attracted to the resorption sites, where they will then attach onto 
bone matrix to differentiate into prefusion osteoclasts with the 
stimulation of M-CSF and the receptor activator of nuclear 
factor kappa-B ligand (RANKL). RANKL is a protein found on 
the surface of the osteoblastic lineage cells, which may also be 
cleaved into a soluble form by metalloproteinases. RANKL 
interacts with its receptor, RANK, expressed on the surface of 
hematopoietic precursor cells thereby promoting osteoclast 
formation and maintaining their viability and activity. The 
continuous stimulation of M-CSF and RANKL induces the 
further differentiation of the prefusion osteoclasts which, by 
fusion, become multinucleated cells. The formation of "ruffled 
membrane", critical for bone resorption, is also stimulated by 
RANKL which promotes the survival of mature osteoclasts.8,10 
Resorption implies an initial tight attachment of osteoclasts to 
the bone surface to create the "sealing zone", rich in F-actin. 
The osteoclast thus isolates the resorptive space from the 
surrounding bone.11,12 The ruffled border is formed by fusion of 
intracellular acidic vesicles which form finger-like projections 
inside the sealing zone. The vesicles contain a cocktail of 
matrix-degrading enzymes (such as cathepsin K), hydrogen 
ions (H+) and chloride ions (Cl−) which are released into the 
resorption lacunae and are responsible for acidification to a pH 
of around 4.5.13-15 This process produces the dissolution of the 
bone mineral component and enhances the enzymatic activity 
on the organic matrix. The degraded bone matrix is 
endocytosed from the resorption lacunae and transported by 
transcytotic carriers to the functional secretory domain, where it 
is released into the extracellular environment.16,17 Although 
these mechanisms of osteoclast action for bone resorption are 
well known, the bone remodelling process is not yet completely 
understood when osteoporosis is present.18 Pathological 
fractures are the natural consequence of osteoporosis and, for 
this reason, much attention has been given to fracture 
prevention through pharmacological and physical therapies. 
However, less attention has been directed at the study of 
orthopaedic biomaterials behaviour when implanted in 
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osteoporotic bone.19 In fact, there are no clinically approved 
biomaterials specifically tailored for application in osteoporotic 
bones. Certainly, there are some examples of medical devices 
for osteosynthesis with special designs, but they are made of 
the same biomaterials than the conventional ones.19 
Biomaterials that enhance the osteogenic function while 
decreasing the osteoclasts-mediated resorption, would be of 
great interest to fabricate implants specially tailored for 
osteoporotic patients. In this sense, nanocrystalline silicon 
substituted hydroxyapatites (nano-SiHA) could play a 
significant role for this biomedical purspose. In 1999, Gibson et 
al proposed SiHA as an improved bioceramic respect to 
stoichiometric hydroxyapatite.20 Thereafter, in vivo studies 
demonstrated that the bioactivity of HA was improved with the 
incorporation of Si.21 This fact is explained in terms of a higher 
solution-mediated degradation of the apatite phase due to 
silicate presence within the crystalline structure, higher 
solubility at the grain boundary and an up-regulation in 
osteoblast cell metabolism in the early stages of bone 
formation.22-27. Since then, Si-substituted HAs have attracted 
the attention of many researchers and have recently been 
incorporated to the biomaterials market for spinal, orthopaedic, 
periodontal, oral and craniomaxillofacial applications. SiHA 
approved for clinical use are highly crystalline bioceramics 
treated at high temperatures. However, the possibility of 
enhancing bioceramics bioreactivity through their preparation 
as nanocrystalline compounds has been suggested.28,29 Higher 
surface area and smaller crystal size could thus provide very 
interesting bioresponses, especially in SiHA as the osteogenic 
effect of silicon is mainly explained by its location at the crystal 
boundaries.22,23  
 
 In vitro cell cultures help to understand the interaction of 
bone remodeling cells with biomaterials.30 In the case of SiHA 
based bioceramics, the majority of in vitro studies are focused 
on the interaction of sintered and highly crystalline Si-HA with 
osteoblasts,31-33 and little is known about the interaction of 
highly crystalline SiHA with bone resorbing osteoclasts.34,35 
The interaction of nanocrystalline SiHA with osteoblasts have 
been also studied by Thian et al.28,36 However, to the best of our 
knowledge, there are none study concerning osteoclast 
interactions with nanocrystalline SiHA. Since bone remodelling 
depends on resorption and new bone formation processes 
carried out by osteoclasts and osteoblasts respectively, in the 
present study we aimed to know the behaviour of osteoclasts on 
both nano-HA and nano-SiHA disks, evaluating their 
differentiation and resorptive activity in vitro. The results 
herein presented open new possibilities for tailoring 
biomaterials specially aimed to osteoporotic bone treatment. 
  
 On the other hand, cells with osteoclastogenic potential also 
exist in blood and peripheral hematopoietic organs and a 
common progenitor for osteoclasts, macrophages, and dendritic 
cells from murine bone marrow has been recently 
characterized.37 The capacity of macrophages to play both 
positive and negative roles in disease processes and tissue 
remodeling after injury, has been recently related to the balance 
between the proinflammatory (M1) and immunomodulatory 
/reparative (M2) macrophage phenotypes, with participation of 
diverse specific cytokines.38,39 Recent studies demonstrate the 
potential of biomaterials to modulate immune cell function, 
suggesting the possibility of designing biomaterials capable of 
eliciting appropriate immune responses at implantation sites.40 
  Previous studies have shown that Saos-2 osteoblasts grow 
better on nanocrystalline SiHA (nano-HA) disks than on 
nanocrystalline HA (nano-HA) disks. Since bone remodelling 
depends on resorption and new bone formation processes 
carried out by osteoclasts and osteoblasts respectively, in the 
present study we aimed to know the behaviour of osteoclasts on 
both nano-HA and nano-SiHA disks, evaluating their 
differentiation and resorptive activity in vitro. With this 
purpose, osteoclast-like cells have been differentiated for the 
first time on these substrates by treatment of RAW-264.7 
macrophages with M-CSF and RANKL. The U0126 inhibitor 
of MAPKs (MEK) was used to potentiate the differentiation 
process. 
 
 
2. Materials and Methods 
2.1. Nanocrystalline hydroxyapatite and silicon substituted 
hydroxyapatite synthesis 
  Samples of pure and silicon substituted HA were prepared 
by aqueous precipitation reaction of Ca(NO3)2·4H2O, 
(NH4)2HPO4 and tetraethyl orthosilicate Si(CH3CH2O)4 
(TEOS) solutions. The amounts of reactants were calculated on 
the assumption that phosphorus would be substituted by silicon. 
Two different compositions have been prepared with nominal 
formula Ca10(PO4)6-x(SiO4)x(OH)2-x, with x = 0 and  0.25  for 
nano-HA and  nano-SiHA samples, respectively, as previously 
reported by Arcos et al.26 Briefly, 1M Ca(NO3)2·4H2O solution 
was added to (NH4)2HPO4 and TEOS solutions of 
stoichiometric concentration to obtain the compositions 
described above. The mixture was stirred for 12 hours at 80°C. 
During the reaction the pH was continuously adjusted to 9.5 to 
ensure constant conditions during the synthesis. The as-
precipitated powders were milled, sieved and treated at 700°C 
for 2 hours under air atmosphere to remove the nitrates without 
introducing important changes in the crystallite size respect to 
the as precipitated powder. The HA and Si-HA particles thus 
obtained have a diameter ranging in size between 10 to 100 
micrometers, whereas the averaged crystallite sizes are 30 nm 
and 24 nm for nano-HA and nano-SiHA, respectively, as 
previously reported.26  
2.2. Preparation of nano-HA and nano-SiHA disks 
 Fractions of 300mg of the as-precipitated powders of HA 
and Si-HA materials were milled, sieved and pressed into disk-
shape (11mm diameter, 2mm height) by means of 3 tons of 
uniaxial pressing. Thereafter the disks were treated at 700°C for 
two hours under air atmosphere. 
2.3. Culture of RAW-264.7macrophages and treatment with 
nano-HA or nano-SiHA 
 RAW-264.7 cells were seeded on 6 well culture plates 
(CULTEK S.L.U., Madrid, Spain) at a density of 105 cells/ml in 
Dulbecco's Modified Eagle Medium (DMEM) supplemented 
with 10% fetal bovine serum (FBS, Gibco, BRL), 1 mM L-
glutamine (BioWhittaker Europe, Belgium), penicillin (200 
µg/ml, BioWhittaker Europe, Belgium), and streptomycin (200 
µg/ml, BioWhittaker Europe, Belgium), under a CO2 (5%) 
atmosphere at 37ºC for 24 h. Then, 1mg/ml of either nano-HA 
or nano-SiHA were added to cultured RAW-264.7 and 
maintained under a CO2 (5%) atmosphere at 37ºC for 24 h. 
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Parallel controls were carried out in the absence of material. 
After this treatment, the attached cells were washed with PBS 
and harvested using cell scrapers.  Then, 10 µl of the cell 
suspensions were counted with a Neubauer hemocytometer for 
the analysis of cell proliferation and cell suspensions were 
centrifuged at 310xg for 10 min and resuspended in fresh 
medium for analysis of different parameters by Flow Cytometry 
as described below (2.6 section). 
2.4. Osteoclast differentiation on nano-HA and nano-SiHA 
disks. 
 Murine RAW-264.7 macrophages were seeded on either 
nano-HA or nano-SiHA disks, previously introduced into 24 
well culture (CULTEK S.L.U., Madrid, Spain), at a density of 
2x104 cells/ml in Dulbecco's Modified Eagle Medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS, Gibco, 
BRL), 1 mM L-glutamine (BioWhittaker Europe, Belgium), 
penicillin (200 µg/ml, BioWhittaker Europe, Belgium), and 
streptomycin (200 µg/ml, BioWhittaker Europe, Belgium). In 
order to stimulate osteoclast differentiation, 40 ng/ml of mouse 
RANK Ligand recombinant protein (TRANCE/RANKL, 
carrier-free, BioLegend, San Diego), 25 ng/ml recombinant 
human macrophage-colony stimulating factor (M-CSF, 
Milipore, Temecula) and U0126 (5 µM Promega, Madison, WI, 
USA) were added to the culture medium. Cells were cultured 
under a CO2 (5%) atmosphere and at 37ºC for 21 days, 
renewing culture medium every 5-7 days. After 21 days culture 
on nano-HA and nano-SiHA disks, cells were washed with 
PBS, harvested using PBS-EDTA during 10 min and counted 
with a Neubauer hemocytometer. Cell suspensions were then 
centrifuged at 310xg for 10 min and resuspended in fresh 
medium for the analysis of different parameters by flow 
cytometry as described below (2.5 section). 
2.5. Flow Cytometry studies 
 After incubation with the different probes, as is described 
below, the conditions for the data acquisition and analysis were 
established using negative and posit 
ive controls with the CellQuest Program of Becton Dickinson. 
These conditions were maintained during all the experiments. 
At least 10,000 cells were analyzed in each sample.  
 2.5.1. Cell cycle analysis and apoptosis detection 
 Cell suspensions were incubated with Hoechst 33258 
(PolySciences, Inc., Warrington, PA) (Hoechst 5µg/ml, ethanol 
30%, and BSA 1% in PBS), used as a nucleic acid stain, during 
30 min at room temperature in darkness. The fluorescence of 
Hoechst was excited at 350 nm and the emitted fluorescence 
was measured at 450 nm in a LSR Becton Dickinson Flow 
Cytometer. The cell percentage in each cycle phase: G0/G1, S 
and G2/M was calculated with the CellQuest Program of 
Becton Dickinson and the SubG1 fraction was used as 
indicative of apoptosis. 
 2.5.2. Intracellular reactive oxygen species (ROS) 
content and cell viability  
 Cells were incubated at 37ºC for 30 min with 100 µM 2´,7´-
dichlorofluorescein diacetate (DCFH/DA, Serva, Heidelberg/ 
Germany) for directly measuring the intracellular content of 
ROS. DCFH/DA is diffused into cells and is deacetylated by 
cellular esterases to non-fluorescent DCFH, which is 
rapidly oxidized to highly fluorescent DCF by ROS. To 
measure the intracellular reactive oxygen species (ROS), the 
DCF fluorescence was excited by a 15 mW laser tuning to 488 
nm and the emitted fluorescence was measured with a 530/30 
band pass filter in a FACScalibur Becton Dickinson Flow 
Cytometer. Cell viability was determined by propidium iodide 
(PI) exclusion test and flow cytometry after addition of PI 
(0.005% in PBS, Sigma-Aldrich Corporation, St. Louis, MO, 
USA) to stain the DNA of dead cells. 
 2.5.3. Intracellular calcium content  
 Cell suspensions were incubated with the probe Indo-1 AM 
at a concentration of 10 µM for 30 min at room temperature, in 
darkness and with shaking. The fluorescence of Indo-1 was 
excited at 325 nm and the emitted fluorescence was measured 
with 380 nm long pass (FL1) and 424/44 nm band pass (FL2) 
filters in a LSR Becton Dickinson flow cytometer. After all the 
measurements, 10 µM A-23187 ionophore (Enzo Life Sciences) 
was added in order to test the sensitivity of the assay. 
2.6. Morphological studies by Confocal Microscopy 
 Cells cultured on nano-HA and nano-SiHA disks were fixed 
with 3.7% paraformaldehyde in PBS for 10 min, washed with 
PBS and permeabilizated with 0.1% Triton X-100 for 3 to 5 
min. The samples were then washed with PBS and preincubated 
with PBS containing 1% BSA for 20 to 30 min. Then cells were 
incubated during 20 min with FITC phalloidin (Dilution 1:40, 
Molecular Probes) to stain F-actin filaments. Samples were 
then washed with PBS and the cell nuclei were stained with 
DAPI (4′-6-diamidino-2′-phenylindole, 3 µM in PBS, 
Molecular Probes). After staining and washing with PBS, cells 
were examined by a LEICA SP2 Confocal Laser Scanning 
Microscope. The fluorescence of FITC was excited at 488 nm 
and the emitted fluorescence was measured at 491-586 nm. 
DAPI fluorescence was excited at 405 nm and measured at 
420–480 nm.  
2.7. Morphological Studies by Scanning Electron 
Microscopy  
 Scanning electron macroscopy and EDX spectroscopy was 
carried out with a JEOL JSM-6400 scanning electron 
microscope. Since gold coating overlap with phosphorous 
signal in the EDX analysis, Nano-HA and Nano-SiHA disks 
were coated with graphite. 
Cells cultured on nano-HA and nano-SiHA disks were fixed 
with glutaraldehyde (2.5% in PBS) for 45 min. Sample 
dehydration was performed by slow water replacement using 
series of ethanol solutions (30, 50, 70, 90%) for 15 min with a 
final dehydration in absolute ethanol for 30 min, allowing 
samples to dry at room temperature and under vacuum. 
Afterwards, the pieces were mounted on stubs and coated in 
vacuum with gold-palladium.  
2.8. Observation of osteoclast resorption cavities by 
Scanning Electron Microscopy  
 To observe the geometry of resorption cavities produced by 
osteoclasts on the surface of nano-HA and nano-SiHA disks, 
cells were detached after 21 days culture on these biomaterials 
and disks were dehydrated, coated with gold-palladium (as in 
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2.8 section) and examined with a JEOL JSM-6400 scanning 
electron microscope. 
2.9. Inflammatory cytokine detection  
 The amounts of TNF-α and IL-6 in the culture medium 
were quantified by ELISA (Gen-Probe, Diaclone), carried out 
according to the manufacturer’s instructions. 
2.10. Statistics 
 Data are expressed as means + standard deviations of one 
representative experiment out of three experiments carried out 
in triplicate. Statistical analysis was performed using the 
Statistical Package for the Social Sciences (SPSS) version 19 
software. Statistical comparisons were made by analysis of 
variance (ANOVA). Scheffé test was used for post 
hocevaluations of differences among groups. In all of the 
statistical evaluations, p < 0.05 was considered as statistically 
significant. 
 
3. Results and discussion 
 Bone remodelling depends on the balance between 
osteoblastic bone formation and osteoclastic bone resorption. 
Differentiation and activity of both osteoblasts and osteoclasts 
are precisely regulated processes and can greatly be influenced 
by the presence of a biomaterial.1 Thus, silicate nanoparticles 
have been recently used in an animal model to stimulate bone 
growth by inhibiting osteoclasts while enhancing the activity of 
osteoblasts.41 However, little is known about the effects on 
osteoclast differentiation/activity produced by the majority of 
biomaterials designed for bone tissue. Silicon substituted 
hydroxyapatites (Si-HA) are among the most interesting 
calcium phosphates for bone repair with comparable 
biocompatibility and mechanical properties to hydroxyapatite 
(HA) but improved bioactivity which enhances bone tissue 
growth rate.22-24,36,42 The beneficial actions of Si-substituted 
calcium phosphates have been recently revised, but the majority 
of studies concerning the Si effects have focused on bone 
formation and osteoblasts.31-33,43-47 In the present study, taking 
into account that osteoclasts derive from a monocyte/ 
macrophage precursor,37 the in vitro effects of nanocrystalline 
hydroxyapatite (nano-HA) and nanocrystalline silicon 
substituted hydroxyapatite (nano-SiHA) on murine RAW-264.7 
macrophages were analyzed, as was the capacity of these cells 
to differentiate into mature osteoclasts on the surface of these 
biomaterials in the presence of soluble RANKL and M-CSF in 
the culture medium. 
 Figures 1A and 1B depict the scanning electron 
micrographs obtained disks of nano-HA and nano-SiHA, 
respectively. Both surfaces show large and irregular particles 
ranging in size between 10 and 50 micrometers. These particles 
do not show the typical polyhedral morphology of highly 
crystalline ceramics treated at high temperature. On the 
contrary, they exhibit irregular shapes with incomplete sintered 
grain boundaries, as would correspond to pressed powders 
treated at temperatures below the sintering point.  
Figures 1C and 1D show the EDX spectra for nano-HA and 
nano-SiHA, which agree with the chemical compositions 
expected for the nominal formulas Ca10(PO4)6(OH)2 and 
Ca10(PO4)5.7(SiO4)0.3(OH)1.7.  
 
  
 
Fig. 1 Scanning electron micrographs (magnification x 2000) obtained 
from disks of nano-HA (A) and nano-SiHA (B). EDX spectra 
corresponding to nano-HA (1C) and nano-SIHA (1D), respectively.  
 
 
 
Fig. 2 Scanning electron micrographs (magnification x 10000) obtained 
from disks of nano-HA (A) and nano-SiHA (B) 
 SEM observations of the surfaces at higher magnifications 
(Figure 2) show that the large grains are formed by 
nanoparticles leaving porosity at the nanoescale.   This is due to 
the low thermal treatment, which is clearly insufficient to lead 
the crystal growth of the as-precipitated nanocrystalline 
powders. The micrographs also evidence the presence of 
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macropores (larger than 50 nm) and surface defects that, from a 
qualitative point view, seem to be more numerous in nano-
SiHA (Figure 2B). 
 Figure 3A shows macrophage proliferation values after 1 
day culture with either nano-HA or nano-SiHA (1 mg/ml in 
powder form). As can be observed, both materials produced a 
significant decrease of RAW-264.7 cell proliferation in 
comparison with controls in the absence of material. This effect 
has been previously observed using cultured L929 fibroblasts, 
Saos-2 osteoblasts and MC3T3-E1 preosteoblasts.24,48   
 
Fig. 3 Effect of 1 mg/ml of powdered nano-HA and nano-SiHA on 
proliferation (A) and intracellular ROS content (B) of RAW-264.7 
macrophages after 1 day treatment. Controls without material were 
carried out in parallel. ***p< 0.005. 
 Increased reactive oxygen species (ROS) formation has 
been described in response of macrophages to different 
hydroxyapatite dispersions.49 When the intracellular ROS 
content of RAW-264.7 macrophages was evaluated by flow 
cytometry with the probe DCFH/DA, after 1 day treatment with 
either nano-HA or nano-SiHA, a significant increase induced 
by nano-HA was observed at this short time of culture. 
However, macrophages treated with nano-SiHA showed lower 
ROS values than control (Figure 3B), thus indicating a 
beneficial action of Si-substituted material in agreement with 
other studies.22-24,36,42,43  
 To know the possible effects of these biomaterials on 
macrophage phenotypes, the analysis of two RAW-264.7 cell 
populations, with high and low intracellular ROS content, was 
carried out in the samples by flow cytometry after DCFH 
labelling. As can be observed in Figure 4, the percentage of 
low ROS population is significantly higher in control and nano-
SiHA samples than in nano-HA treated cells, whereas the high 
ROS population is significantly higher in nano-HA compared 
with nano-SiHA and control. The two populations observed, 
can be related to the proinflammatory (M1, high ROS) and 
reparative (M2, low ROS) macrophage phenotypes, whose 
balance has been involved in the macrophage capacity to play 
both negative and positive roles in disease processes and tissue 
remodelling after injury.38,39 Although further studies are 
necessary to establish the effects of these nanocrystalline 
hydroxyapatites on macrophage polarization, the results 
obtained suggest the beneficial role of nano-SiHA which could 
favour the reparative population with low ROS content. In this 
sense, recent studies suggest the potential of biomaterials to 
modulate immune response at implantation sites.40 
 
Fig. 4 Effect of 1 mg/ml of powdered nano-HA and nano-SiHA on 
RAW-264.7 macrophage populations concerning intracellular ROS 
content after 1 day treatment. Controls without material were carried 
out in parallel. ***p< 0.005. 
 In order to evaluate the action of nano-HA and nano-SiHA 
on osteoclast differentiation and resorptive activity in vitro, 
osteoclasts were differentiated by treatment of RAW-264.7 
macrophages with M-CSF and RANKL on the surface of disks 
prepared with these biomaterials. The U0126 inhibitor of 
MAPKs (MEK) was used to potentiate the differentiation 
process.50 As can be observed in Figures 5 and 6, continuous 
stimulation with these factors induces osteoclast-like cell 
differentiation on both materials by fusion of macrophagic 
precursors leading to multinucleated cells (asterisks indicate the 
nuclei in the insets of Fig. 5A and 5B, and in Fig. 6D). The 
formation of long and numerous finger-like projections 
(podosomes) was also observed (thin arrows in Fig. 5C and 5D 
and Fig. 6), as well as the F-actin ring which allows creation of 
the "sealing zone" (thick arrows in Fig. 5B and 6C), which is 
critical for bone resorption.  
 
 
 
Fig. 5 Morphology evaluation by Confocal Microscopy of osteoclast-
like cells cultured on nano-HA disks, stained with DAPI (for the 
visualization of the cell nuclei) and FITC phalloidin (for the 
visualization of cytoplasmic F-actin filaments). Asterisks indicate the 
nuclei, thin arrows the podosomes and thick arrows the F-actin ring of 
the "sealing zone". 
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Fig. 6 Morphology evaluation by Confocal Microscopy of osteoclast-
like cells cultured on nano-SiHA disks, stained with DAPI (for the 
visualization of the cell nuclei) and FITC phalloidin (for the 
visualization of cytoplasmic F-actin filaments). Asterisks indicate the 
nuclei, thin arrows the podosomes and thick arrows the F-actin ring of 
the "sealing zone". 
 All these morphological characteristics reveal the 
osteoclastogenesis on these nanocristallyne hydroxyapatites in 
agreement with other studies carried out with carbonate-
substituted hydroxyapatite.51 However, some differences were 
observed between osteoclast-like cells differentiated on nano-
HA and nano-SiHA disks. A higher number of nuclei per cell 
was observed on nano-HA surface (asterisks in the insets of 
Fig. 5A and 5B) than on nano-SiHA disks (asterisks in Fig. 
6D). The statistical analysis of the multinucleated cells showed 
10% of multinucleated cells on both materials. However, in 
contact with nano-SiHA, these multinucleated cells contain two 
nuclei and the multinucleated cells on nano-HA disks contain 
four or five nuclei. Although the formation of F-actin ring and 
podosomes, related to the definition of the sealing zone, was 
observed on both materials, more organized podosomes were 
evident in the cells differentiated on nano-HA (thin arrows in 
Fig. 5C and 5D) than on nano-SiHA (thin arrows in Fig. 6C). 
All these results reveal that nano-SiHA produces a delay in the 
osteoclastogenesis probably due to the presence of Si. In this 
sense, experiments with RAW-264.7 macrophages demonstrate 
that Si affects the late stages of differentiation and fusion of 
osteoclasts, causing a significant inhibition of osteoclast 
phenotypic gene expressions, osteoclast formation and bone 
resorption in vitro.52 
 Figure 7 shows the proliferation (A) and cell viability (B) 
of osteoclast-like cells differentiated on nano-HA and nano-
SiHA disks. As it can be observed in Figure 7A, the cell 
growth on nano-SiHA surface was significantly lower than on 
nano-HA disks after 21 days. However, high viability values on 
both biomaterials (up 80 %) were obtained (Fig. 7B). The 
significant decrease of osteoclast proliferation produced by 
nano-SiHA, probably due to the presence of Si, is in agreement 
with the powdered nano-SiHA action on RAW-264.7 cells (Fig. 
3A), and can be related to the same origin of both cell types 
from a monocyte/macrophage precursor.37 Previous results 
have shown a significant Ca2+ decrease in the culture medium 
produced by both nano-HA and nano-SiHA, more pronounced 
with nano-SiHA, in agreement with the higher bioactivity of 
this material.42,53 The observed sequestration of extracellular 
calcium can be partially responsible of the lower proliferation 
of osteoclasts on nano-SiHA observed in the present study. 
Recently, it has been observed that bioglass 45S5 particles 
cause a significant reduction of osteoclast-like cells in both the 
marrow cultures and RAW-264.7 cells, suggesting a direct 
inhibitory effect of Si on the osteoclast precursors that is not 
due to cell toxicity.52 However, previous studies with Saos-2 
osteoblasts showed that the number of Saos-2 cells after 4 days 
culture in contact with nano-SiHA was significantly higher than 
with nano-HA, indicating that this cell type grows better in the 
presence of nano-SiHA. This result was also observed by 
Scanning Electron Microscopy (SEM) when Saos-2 osteoblasts 
were cultured for 4 days on surface of both nano-HA and nano-
SiHA disks. SEM images demonstrated that Saos-2 cells adhere 
to the nano-SiHA disk, proliferate and colonize its surface 
better than on nano-HA disk.24 Previous studies also showed 
that osteoblasts cultured on nano-SiHA surface showed the 
typical bone cell morphology, cube-shape, and big sized, 
joining other cells to construct a net through strong cellular 
union.24 Adhesion and proliferation processes are good 
indicators of the cell response that could be expected when a 
biomaterial is used in vivo. Thus, the previous results obtained 
with osteoblasts cultured on nano-SiHA disks indicates a good 
biocompatibility and an adequate interaction of osteoblasts with 
nano-SiHA material. 
 
 
 
Fig. 7 Proliferation (A) and cell viability (B) of osteoclast-like cells 
cultured on nano-HA and nano-SiHA disks. ***p< 0.005. 
 
 Since proliferation is dependent on the cell cycle 
progression, in which cells pass through the G0/G1 phase 
(Quiescence/Gap 1) to the S phase (Synthesis) and finally to the 
G2/M phase (Gap 2 and Mitosis), the cell cycle phases of 
osteoclast-like cells cultured on nano-HA disks and nano-SiHA 
disks were analysed. No significant changes were observed 
(Figure 8), demonstrating that these materials do not produce 
toxicity on osteoclast-like cells, in agreement with the results 
obtained from the propidium iodide exclusion test (Figure 7B). 
The analysis of SubG1 fraction, corresponding to cells with 
fragmented DNA, reveals low apoptosis levels induced by both 
materials (Figure 8) but slightly higher on nano-SiHA than on 
nano-HA (Figure 9A). 
 
 Intracellular ROS and Ca2+ play essential roles for 
osteoclastogenesis.54 Thus, following stimulation with RANKL, 
the pre-osteoclasts increase intracellular ROS by activation of 
NADPH oxidase (Nox) homologs or by increased mitochondria 
ROS production, which subsequently induced long lasting Ca2+ 
oscillations.54-56 In the present study both intracellular ROS and 
Ca2+ content of osteoclast-like cells cultured on nano-HA disks 
and nano-SiHA disks were analyzed by Flow Cytometry and 
higher values of both parameters were obtained in cells cultured 
on nano-SiHA than on nano-HA (Fig. 9B and 9C). These 
results could suggest the existence of a differentiation delay 
produced by nano-SiHA on RAW-264.7 cells, in agreement 
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with the morphological characteristics observed by Confocal 
Microscopy (Fig. 5 and 6).  
 
 
Fig. 8 Effect on cell cycle phases of osteoclast-like cells cultured on 
nano-HA disks (A) and nano-SiHA disks (B). 
 
   
 
 
Fig. 9 Effect on apoptosis (A), ROS production (B) and cytosolic Ca2+ 
(C) of osteoclast-like cells cultured on nano-HA and nano-SiHA disks. 
*p< 0.05. 
 
 Figure 10 shows by Scanning Electron Microscopy (SEM) 
the morphology of RAW-264.7 macrophages differentiated into 
osteoclast-like cells cultured on nano-HA disks (Fig. 10A and 
10B) and nano-SiHA disks (Fig. 10C and 10D). These SEM 
studies demonstrate the presence of cells attached on both 
surfaces, presenting typical characteristics of osteoclasts with 
many longer podosomes.  
 
 
 
Fig. 10 Morphology evaluation by Scanning Electron Microscopy of 
osteoclast-like cells cultured on nano-HA disks (A,B) and nano-SiHA 
disks (C,D). 
 
 In order to evaluate the geometry of the resorption cavities 
left by osteoclast-like cells cultured on nano-HA and nano-
SiHA samples, the surfaces of these materials were analyzed by 
SEM after cell detachment. As can be observed in Figure 11, 
osteoclasts cultured on nano-HA disks demonstrate higher 
resorptive activity (Fig. 11A and 11B) than on nano-SiHA 
disks (Fig. 11C and 11D) after 21 days culture in the presence 
of RANKL, M-CSF and U0126. Resorption cavities on nano-
HA surface present higher size than on nano-SiHA surface 
which shows spherical cavities (inset in Figure 11D). The 
statistical analysis of the cave size showed values of 10 ± 1.7 
µm on nano-SiHA and 32.5 ± 9.7 µm on nano-HA (**p<0.01).  
Concerning the resorption of nanocrystalline calcium 
phosphates by osteoclast-like cells, Detsch et al. have recently 
showed that nano-HA with low carbonate content strongly 
stimulated the differentiation and resorption of these cells on its 
surface when compared with carbonate-rich samples.12 
   
 
 
Fig. 11 Morphology evaluation by Scanning Electron Microscopy of 
the resorption cavities left by osteoclast-like cells cultured on nano-HA 
disks (A, B) and nano-SiHA disks (C,D). 
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 Resorption implies an initial tight attachment of osteoclasts 
to the disk surface to create the "sealing zone", rich in F-actin, 
which isolates the resorptive space from the surrounding 
material.11,12 The ruffled border is formed by fusion of 
intracellular acidic vesicles which contain enzymes (such as 
cathepsin K), Cl− and H+ ions which are released into the 
resorption lacunae for the acidification to a pH of around 4.5.13-
15 This process produces the dissolution of the material, which 
is then endocytosed from the resorption cavity and transported 
to the secretory domain for releasing into the extracellular 
environment.16,17 
 
 Many different stimuli have been shown to regulate Ca2+ 
concentrations in osteoclasts and extracellular acidification has 
been described as causing a decrease in intracellular Ca2+ 
concentration in isolated chicken osteoclasts.57 The lower Ca2+ 
content observed in the present study with osteoclast-like cells 
cultured on nano-HA disks in comparison to cells cultured on 
nano-SiHA samples (Figure 9C) can be related to higher 
extracellular acidification produced by these cells on nano-HA 
surface than on nano-SiHA surface, as demonstrated by the 
geometry of the resorption cavities observed on this material 
(Fig. 11A and 11B). 
 
 Since it has been found that osteoclast differentiation is 
induced by tumor necrosis factor (TNF)-α and IL-6,58,59 these 
cytokines were evaluated in the culture medium of RAW-264.7 
macrophages at different times during the differentiation into 
osteoclast-like cells on nano-HA disks and nano-SiHA disks. 
As can be observed, both TNF-α (Figure 12A) and IL-6 
(Figure 12B) levels increased progressively in the culture 
medium during osteoclast differentiation. The values of both 
cytokines were always significantly higher in the presence of 
nano-SiHA than nano-HA. 
 
 Taking into account that TNF-α and IL-6 modulate 
osteoclastogenesis, the increase of these cytokines in the 
presence of nano-SiHA could be explained by a higher 
secretion as a response to stimulate the differentiation process 
which is delayed on this material. However, in mouse bone 
marrow-derived macrophages (BMMs), IL-6 decreased 
osteoclast formation and bone-resorption ability.60 Taking into 
account the results obtained with BMMs, the nano-SiHA 
effects on osteoclastogenesis and resorption activity observed 
in the present study, also could be caused by an increase of IL-6 
induced by this material (Figure 12B). Other cytokines as 
TNF-α and IL-1β, showed various responses according to the 
phase of osteoclast maturation and the concentration of each 
cytokine and RANKL.60 
 
 
 
 
Fig. 12 Effects on TNF-α (A) and IL-6 (B) release to culture medium of 
osteoclast-like cells cultured on nano-HA and nano-SiHA disks.  
*p< 0.05, **p<0.01, ***p< 0.005. 
 
 Conclusions 
  
 Since bone is a dynamic tissue in continuous remodelling 
which depends on resorption and new bone formation processes 
carried out by osteoclasts and osteoblasts respectively, in the 
present study we aimed to know the behaviour of osteoclasts on 
both nano-HA and nano-SiHA disks, evaluating for the first 
time the differentiation and the substrate resorption carried out 
by this cell type on both substrates. This study demonstrates 
that nanocrystalline Si-substituted hydroxyapatite delays the 
osteoclast differentiation and decreases the resorptive activity 
of these cells on their surface, as compared to nanocrystalline 
hydroxyapatite, without affecting cell viability. Furthermore, 
the demonstrated increase of the reparative macrophage 
population, along with the beneficial effects on osteoblasts 
previously observed with powdered nano-SiHA, suggest the 
potential of this biomaterial for modulating the fundamental 
processes of bone formation and turnover, preventing bone 
resorption and enhancing bone formation at implantation sites 
in treatment of osteoporotic bone and in bone repair and 
regeneration. 
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                  Madrid, January 24, 2014 
Dear Editor: 
Concerning our revised manuscript entitled “NANOCRYSTALLINE SILICON SUBSTITUTED 
HYDROXYAPATITE EFFECTS ON OSTEOCLAST DIFFERENTIATION AND RESORPTIVE ACTIVITY” 
(Manuscript ID TB-ART-11-2013-021697), we have taken the Reviewers´ comments into 
account and I am glad to send you the revised version of the manuscript which includes all the 
changes made highlighted. The authors thank the comments of the reviewers aimed to 
improve the quality of our manuscript. A detailed list of these changes and the responses to 
the Reviewers' comments is included below. 
 
Referee: 1 
Comments to the Author 
In this manuscript, Matesanz and coworkers investigated the effects of nanocrystalline silicon 
substituted hydroxyapatite (Nano-SiHA) on the differentiation and resorptive activity of human 
osteoclast cells. By the experimental data, they concluded that the Nano-SiHA can delay the 
osteoclast differentiation and decreased the resorptive activity of cells on substrates. This 
manuscript was well-written and well-organized, but it is clear that the novelty and 
significance are not enough for the publication on JMCB (see previous reports like: 
Biomaterials, 2006, 27, 2692; J Biomed Mater Res A, 2006, 78A, 709; J Biomed Mater Res A, 
2006, 79A, 723) and some of the conclusions are needed to further consider and proved. 
Therefore, this manuscript is not recommended for publication at presented version, but it 
may be considered after a major revision and resubmission. 
Authors 
 After considering the reviewer’s comments regarding the lack of novelty and 
significance of our manuscript, the authors think that we failed in explaining these aspects in 
the first version. We hope that this revised version will satisfy the standards of JMCB. 
Anyway, we want to clarify herein the novelty and significance of our work. After the article 
of Gibson et al (J Biomed. Mater Res 1999, 44, 422), the interest for these bioceramics has 
continuously increased during the last 15 years. Regarding cell culture studies, there are 
numerous articles dealing with the interaction of sintered and highly crystalline Si-HA with 
osteoblasts (for instance the article suggested by the reviewer Botelho et al. J Biomed Mater 
Res A, 2006, 79A, 723) and a few ones considering osteoclasts, specifically Botelho et al. J 
Biomed Mater Res A, 2006, 78A, 709 and Lehmann et al Biomed Mater 2012, 7, 055001. The 
interaction of nanocrystalline Si-HA with bone cells have been also studied by Thian et al.  
Biomaterials, 2006, 27, 2692 (as the reviewer pointed out), but that work was carried out 
with osteoblasts. To the best of our knowledge, our manuscript is the first study about the 
interaction of nanocrystalline Si-HA with osteoclasts.  
 In order to determine the role of the silicon within nanocrystalline HA on the 
osteoclasts behaviour, we have compared our compounds with pure nano HA. The results 
Page 11 of 19 Journal of Materials Chemistry B
indicate that nano-SiHA disks delayed the osteoclast differentiation and decreased the 
resorptive activity of these cells on their surface, as compared to nano-HA samples, without 
affecting cell viability. These results along with the beneficial effects on osteoblasts 
previously observed with powdered nano-SiHA suggest the potential of this biomaterial for 
bone repairing specially in osteoporotic patients. This finding is of great significance, since 
there are no clinically approved biomaterials specifically tailored for application in 
osteoporotic bones. Certainly, there are some examples of medical devices for osteosynthesis 
with special designs, but they are made of the same biomaterials than the conventional ones 
(D. Arcos et al, The relevance of biomaterials to the prevention and treatment of 
osteoporosis. Opinion paper, Acta Biomaterialia (2014) DOI 10.1016/j.actbio.2014.01.004.)  
 We hope that this answer will change the reviewer’s mind respect to the degree of 
novelty and significance of our manuscript. The authors thank the comments and the 
references pointed by the reviewer, insofar they have helped to improve the discussion of 
this work. 
 
Referee 1. 
1. In the “introduction” part, it is suggested that the authors should put more attentions on 
the biomedical application of Nano-SiHA, and provide more information on the previous 
studies on cell culture on Nano-SiHA and Nano-HA substrates. 
 
Authors 
 The authors agree with the reviewer’s comment. The potential application nano-SiHA 
for bone tissue repairing in osteoporotic patients is highlighted in the revised version. In an 
osteoporotic scenario, the paucity of bone and the decreased osteoblasts function result in 
an impaired response to implants compared with healthy bones. The osteointegration in 
these cases is seriously affected, mainly due to the decreased osteoblast activity. An 
osteoporotic environment strongly affects the primary (short-term) stability of the implant, 
because the quality of the host bone is significantly decreased. Moreover, biological stability 
(early and long-term) is also impaired, as it requires deposition of newly formed bone in 
intimate contact with the implant. Since this process involves the balanced action of 
osteogenic and bone resorbing cells, osteoporosis often has a poor prognosis and delayed 
healing and osteointegration with endosseous implants. Nano-SiHA presented in this work, 
indicates capability to enhance osteoblastic function while delaying the osteoclast mediated 
bone resorption. For this reason, the authors strongly believe that nano-SIHA is a very 
interesting biomaterial addressed to treat bone defects in osteoporotic patients.   
In this new version, more attention has been paid to previous studies with nano SiHA and 
nano HA. New references, including those proposed by the reviewer, have been added. 
 
2.  In addition, in the “Introduction” part, the authors should point out the novelties and 
significances of their work. What are the improvements compared to previous studies? It is 
unclear in the present version.  
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Authors 
 As mentioned above, the authors think that we failed in explaining these aspects in 
the first version. The novelties and significances respect to previous works have been 
highlighted in this new version. 
 
3.      In the previous studies of the osteoblast differentiation on Nano-SiHA substrate (for 
example, Biomaterials, 2006, 27, 2692), researchers found that the growth of cells on Nano-
SiHA can be significantly enhanced. But in this manuscript, the authors concluded that the 
Nano-SiHA delayed the cell differentiation and decreased the resorptive activity of cells on 
surface. What are the differences between the cell experiments of osteoblast and osteoclast? 
Why the authors used the osteoclast cells in this study? More information should be provided.  
Authors 
 Concerning the previous studies on cell culture on both nanocrystalline materials, 
when Saos-2 osteoblasts were cultured for 4d on surface of both nano-HA and nano-SiHA 
disks, Scanning Electron Microscopy images demonstrated that Saos-2 cells adhere to the Si-
HA disks, proliferate and colonize their  surface better than on HA disks (reference 28). 
Previous studies also showed that osteoblasts cultured on nano-SiHA surface showed the 
typical bone cell morphology, cube-shape, and big sized, joining other cells to construct a net 
through strong cellular union (reference 28). Adhesion and proliferation processes are good 
indicators of the cell response that could be expected when a biomaterial is used in vivo. 
Thus, our previous results obtained with osteoblasts cultured on nano-SiHA disks indicates a 
good biocompatibility and an adequate interaction of osteoblasts with nano-SiHA material. 
In the present study we used osteoclasts because bone is a dynamic tissue in continuous 
remodelling which depends on resorption and new bone formation processes carried out by 
osteoclasts and osteoblasts respectively. Thus, in the present study our objective was to 
know the behaviour of osteoclasts cultured on both nano-HA and nano-SiHA disks, 
evaluating for the first time the differentiation and the substrate resorption carried out by 
this cell type on both substrates. Concerning the resorption of nanocrystalline calcium 
phosphates by osteoclast-like cells, Detsch et al. have recently showed that nano-HA with 
low carbonate content strongly stimulated the differentiation and resorption of these cells 
on its surface when compared with carbonate-rich samples [Reference 12]. These data and 
more comments on our previous results with human Saos-2 osteoblasts have been included 
in the revised version of the manuscript (in the Introduction, Results/discussion and 
Conclusions sections) in order to provide more information and to highlight the novelties and 
significances of our work, as suggested by the reviewer. 
 
4.      In Figure 3 and 4, the captions for the figures are not clear. 
Authors 
 More information is now provided in the captions of Figures 3 and 4 in order to 
clarify the confocal images explaining that asterisks indicate the nuclei in the insets, thin 
arrows indicate the podosomes and thick arrows the F-actin ring which allows creation of the 
"sealing zone" for bone resorption. 
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 5.      In Figure 5, it is clear that the cell growth at the beginning on Nano-SiHA substrate is 
clearly slower than that on Nano-HA, but at the long period it on the same level. What is the 
reason? More explanation should be given.  
Authors 
 Figure 5 (fig 7 in revised version) shows the proliferation (A) and cell viability (B) of 
RAW-264.7 macrophages differentiated into osteoclast-like cells cultured on nano-HA and 
nano-SiHA disks after 21 days. As it can be observed in Figure 5A, the cell growth of 
osteoclast-like cells on nano-SiHA surface was significantly lower than on nano-HA surface 
after 21 days. The values presented in Figure 5B correspond to viability values which are on 
the same level but this Figure 5B does not correspond to cell growth at a longer period. These 
explanations have been improved in the revised version of the manuscript. 
 
6.      For the conclusion for Figure 8, the authors indicated that “cells attached on ….obtained 
by confocal microscopy”. It is clear that there is no difference of cells between the Nano-SiHA 
and Nano-HA substrates. The authors indicated “shorter and thicker” of cells on Nano-HA, but 
this situation can be also found for the cells on Nano-SiHA substrate. Therefore, the conclusion 
is not supported by the data. 
 
Authors 
 Since the Scanning Electron Microscopy images do not show clear differences 
between the podosomes of the cells attached on nano-HA and nano-SiHA, the conclusion for 
Figure 8 (fig 10 in the revised version) has been eliminated in the revised manuscript, as 
suggested by the reviewers 1 and 2. 
 
7.      In Figure 9, the authors provided the SEM images of substrates after recorption of cells. It 
is seemed that these images can reveal nothing, because there is only one resorption cave. 
Images with more caves should be presented. In addition, a statistical analysis of the cave size 
is needed.  
Authors 
 The SEM images in figure 9 (fig 11 in revised version) correspond certainly to caves 
produced by the resorptive activity of osteoclasts cultured on nano-HA and nano-SiHA disks 
because the size of these caves are in the size range of cells and because these caves were 
not observed on disks without cells. The two images which are included below correspond to 
nano-HA and nano-SiHA disks without cells and these samples did not show caves with size 
similar to cell size. These two images have not included in the revised manuscript to avoid an 
excess of figures. As suggested by the reviewer, we have considered more caves to carry out 
the statistical analysis of the cave size obtaining values of 10 ± 1.7 µm (on nano-SiHA) and 
32.5 ± 9.7 µm (on nano-HA). The statistical significance of these values was **p<0.01. These 
data have been included in the text of the revised manuscript. 
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8.      Characterizations of Nano-SiHA and Nano-HA (SEM, XPS) are suggested. 
 
Authors 
 Following the reviewer’s suggestions, SEM an EDX studies have been carried out. The 
results and discussion are included in this revised version.  XPS experiments will be made in a 
future work. 
 
 
Referee: 2 
1.      Materials and methods: 
In 2.1, full name of TEOS (Si(CH3CH2O)4) should be presented in the first time when it 
appeared. 
“The samples are treated at 700 degree……”: what kind samples? Dried samples? Dried at 
which temperature? 
“The HA and Si-HA grains thus obtained have a diameter ranging ……”: does “the grain size” 
mean “the particle size”? 
In 2.2, the authors used the Nano-HA and nano-siHA disks produced by uniaxial pressing on 
300mg powders. Does the disc strong enough for manipulation during cell culture process? 
In section 2.3, “Costar tanswells membranes were then placed into wells ……..parallel controls 
were carried out in the absence of materials”. How were the cells of control groups cultured? 
were they growing on the Costar Transwell membranes? During the culture period (7 days), 
was the medium refreshed. 
Authors 
 Following the reviewers suggestions, the full name for TEOS “tetraethyl orthosilicate, 
Si(CH3CH2O)4, (TEOS)” is presented in the first time it appears.   
 In order to clarify the processing of the different samples (powder and disks) the 
experimental section has been rewritten with the changes highlighted in the text. The 
temperature processing for all kind of samples (powder and disks) are clearly indicated in 
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this new version. Regarding the mechanical strength of the disks, it must be said that they 
are strong enough to be manipulated during the cell culture process. 
 Concerning section 2.3, the text has been corrected because the results included in 
the present study correspond to RAW-264.7 cells which were cultured in direct contact with 
1mg/ml of either nano-HA or nano-SiHA for 24 h. Thus, Costar Transwell membranes were 
not used for these assays. The cells of control groups were cultured in parallel in the absence 
of material at the same experimental conditions. 
 
 
2.      3. Results and discussion: “To know the possible effects of these biomaterials on 
macrophage phenotypes, the ……, with high and low intracellular ROS content, was carried out 
in the samples” How was this experiment done? The author should add this information in the 
experimental section. Especially, how to control the ROS content in two RAW-264.7 cell 
populations? 
Authors 
 2'-7'-Dichlorodihydrofluorescein diacetate (DCFH/DA) is one of the most widely used 
probes for directly measuring the intracellular content of reactive oxygen species (ROS). 
DCFH/DA is diffused into cells and is deacetylated by cellular esterases to non-fluorescent 
2',7'-Dichlorodihydrofluorescin (DCFH), which is rapidly oxidized to highly fluorescent  DCF  by 
ROS. The detection of two RAW macrophage populations with high and low intracellular ROS 
is possible by flow cytometry which  allows simultaneous multi-parameter analysis of single 
cells. This information has been included in the revised manuscript (sections  2.5.2 and 3). 
 
3.      What are Figure 3 (and 4) A, B, C and D representing? Please indicate in their figure 
captions? it is better if the author can provide statistic results of each numbers of the 
multinucleated cells on the nano HA and SiHA samples! 
Authors 
 More information is now provided in the captions of Figures 3 and 4 (figs 5 and 6, 
respectively in the revised version) in order to clarify the confocal images explaining that 
asterisks indicate the nuclei in the insets, thin arrows indicate the podosomes and thick 
arrows the F-actin ring which allows creation of the "sealing zone" for bone resorption. As 
suggested by the reviewer, a statistical analysis of the multinucleated cells on the nano-HA 
and nano-SiHA has been carried out obtaining values of 10% of multinucleated cells on both 
materials. However, in contact with nano-SiHA, these multinucleated cells contain two nuclei 
and the multinucleated cells on nano-HA disks contain four or five. These data have been 
included in the text of the revised manuscript. 
 
4.      In Figure 8, cells in figure 8b are more spread out than those in figure 8d, in addition, 
there are both round-shaped and spread-out cells on both samples (Figure 8a and c), which 
make it difficult to compare the thickness of the cells. 
Authors 
 Since the Scanning Electron Microscopy images do not show clear differences 
between the podosomes of the cells attached on nano-HA and nano-SiHA, the conclusion for 
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Figure 8 (fig 10 in the revised version) has been eliminated in the revised manuscript, as 
suggested by the reviewers 1 and 2. 
 
5.      Regarding the resorption cavity in Figure 9, how sure were the authors about the fact 
that the pits observed on the SEM pictures were resorption cavity? As the HAP is 
biodegradable, it is highly possible that some erosion pits formed under the influence of the 
culture medium during 21 days of incubation. Did the author set a control which is HAp discs 
without osteoclast-like cells incubated for 21 days in cell culture medium? And the authors are 
also suggested to provide the SEM pictures of the discs before cell culture. As the discs made 
by mechanical pressing without densification by sintering, the cavity is also possibly formed by 
the delamination of the “powder debris” from the discs after long-term immersion in liquid. 
Authors 
 As we have explained above in point 7 of reviewer 1, the SEM images in figure 9 (fig 
11 in revised version) correspond certainly to caves produced by the resorptive activity of 
osteoclasts cultured on nano-HA and nano-SiHA disks because the size of these caves are in 
the size range of cells and because these caves were not observed on disks without cells 
(before and after incubation in cell culture medium). The two images which are included 
above in point 7 of reviewer 1 correspond to nano-HA and nano-SiHA disks without cells and 
these samples did not show caves with size similar to cell size. These two images have not 
included in the revised manuscript to avoid an excess of figures. As suggested by the 
reviewer 1 in point 7, we have considered more caves to carry out the statistical analysis of 
the cave size obtaining values of 10 ± 1.7 µm (on nano-SiHA) and 32.5 ± 9.7 µm (on nano-
HA). The statistical significance of these values was **p<0.01. These data have been included 
in the text of the revised manuscript. 
Following the reviewer’s suggestion, SEM studies and EDX spectroscopy have been included 
in the revised version (figures 1 and 2). 
 
6.      Both HA and Si-HA are biodegradable, and also the incorporation of Si must influence the 
dissolution of Ca and P in the Si-HA as the crystalline lattice was changed. Therefore, as the Ca 
and P also potentially influence the activity of osteoclasts in a dose-dependent manner, 
together with the fact that the Ca and P released from the nano HA and SiHA are different, is it 
not scientifically accuracy to conclude the difference in the osteoclastic behaviours observed 
on the HA and SiHA discs were solely caused by Si ions. Have the authors looked at the ion 
release profiles of both discs? And how did the Ca and P ions influence the behaviours of 
osteoclasts seeded on their surfaces? 
Authors 
 Since the hydroxyapatite bioactivity could produce the sequestration of calcium in 
the extracellular medium, and taking into account that the Ca2+ ion plays a crucial role in cell 
processes, Ca
2+
 levels were measured recently in the culture medium during previous studies 
with macrophages and both materials [M.C. Matesanz et al., Journal of Colloid and Interface 
Science 416 (2014) 59–66, new reference 46]. Previous results have shown a significant Ca2+ 
decrease in the culture medium produced by both nano-HA and nano-SiHA, more pronounced 
with nano-SiHA, in agreement with the higher bioactivity of this material [34]. The observed 
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sequestration of extracellular calcium can be partially responsible of the lower proliferation 
of osteoclasts on nano-SiHA observed in the present study. These previous results concerning 
extracellular calcium have been commented in the revised manuscript and related with the 
significant lower cell growth on nano-SiHA than on nano-HA disks observed in the present 
study (Figure 7A in the new version). 
 
 
 
Referee: 3 
 
1.      Authors should conduct more experiments to confirm that the Si ions are the major 
factor to contribute the decreased osteoclastogenesis. Therefore, authors should apply pure Si 
ions with different concentrations to interact with osteoclasts and further explore the 
osteoclastogenesis.  
Authors 
 The biological effects of silicon on bone cells like osteoblasts and osteoclasts have 
already been studied by other authors [34,36, 45], demonstrating that silicon has a dual role 
in bone: it enhances osteoblasts proliferation and differentiation, whereas it causes an 
inhibition of osteoclast gene-expression, osteoclast formation and bone resorption in vitro 
[45]. Dose-dependent effects of Si on osteoclast development and resorption have been 
documented in vitro[34]. Nevertheless, it is still unclear whether these effects are directly 
caused by the silicon ions released by the Si-substituted calcium phophates. However, it is 
known that silicon ions affect calcium solubility [36], which in turn, has an influence on 
biological activity of osteoblasts and osteoclasts. As we have indicated above (point 6 of 
reviewer 2), previous results have shown a significant Ca2+ decrease in the culture medium 
produced by both nano-HA and nano-SiHA, more pronounced with nano-SiHA [46], in 
agreement with the higher bioactivity of this material [34]. The observed sequestration of 
extracellular calcium can be partially responsible of the lower proliferation of osteoclasts on 
nano-SiHA observed in the present study.  To sum up, the role of silicon on 
osteoclastogenesis is clear enough so it makes no necessary to conduct more experiments to 
confirm the effect of Si ions. However, the authors thank the reviewer and will take into 
account the suggestions for future studies. 
 
2.      Rankle and OPG should be investigated for the osteoclastogenesis.  
Authors 
 It is well known the importance of the RANKL/RANK/OPG system in the control of 
bone remodelling (Pivonka et al., Journal of Theoretical Biology, 2010; Boyce et al., Archives 
of Biochemistry and Biophysics, 2008; Wada et al, TRENDS in Molecular Medicine, 2006). The 
biological activity of osteoblasts and osteoclasts is closely coordinated, so the correct 
balance between both cell type activities is of extreme importance. In this sense, osteoblasts 
produce some molecules like RANKL and OPG in order to regulate osteoclasts function. For 
this reason, cocultive studies with osteoblasts and osteoclasts are currently being carried out 
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which are closer to an in vivo situation. These results will be published in the near future. 
Nevertheless, authors thank the reviewer and will take into account his suggestions for 
future studies. 
 
 
I do hope you will consider the reviewed manuscript suitable for publication.  
 
Thanking you very much for your attention, I remain 
 
Sincerely yours 
 
 
Prof. M. Teresa Portolés 
Departamento de Bioquímica y Biología Molecular I 
Facultad de Ciencias Químicas 
Universidad Complutense, 28040-Madrid, Spain 
E-mail: portoles@quim.ucm.es 
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